StockData
Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc. (CMPX) stock

CMPXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$0.66−0.11 (-14.51%)

Close on Nov 16, 2026Market cap $119.13MP/E –Yield –

Compass Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Compass Therapeutics's price to sales ratio was 301.6× on Apr 30, 2025.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025301.6×–

More Compass Therapeutics figures

See a number that looks wrong?